Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ralimetinib × Clear all

Phase

Phase 1 2 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cisplatin 1307 Carboplatin 1226 Cyclophosphamide 1166 Gemcitabine 1062 Bevacizumab 1057 Paclitaxel 1047 Radiotherapy 1033 Docetaxel 956 pembrolizumab 889 Oxaliplatin 803 Capecitabine 787 Fluorouracil 740 Rituximab 644 Doxorubicin 582 Nivolumab 580 Dexamethasone 578 Etoposide 574 Irinotecan 550 Leucovorin 511 Pemetrexed 438 Drug Therapy 415 Cetuximab 409 Cytarabine 406 Trastuzumab 401 Magnetic Resonance Spectroscopy 388 Filgrastim 384 Prednisone 369 Lenalidomide 352 Bortezomib 348 Temozolomide 344

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02322853 2017-05-24

OLYMPE

Centre Francois Baclesse

Phase 2 Terminated

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡